Large Tumor Suppressor (LATS)
Large Tumor Suppressor
LATS is a type of highly conserved serine/threonine protein kinase, belonging to the AGC kinase family. It mainly consists of two homologous members, LATS1 and LATS2. The two have a high degree of functional overlap and are widely involved in processes such as tumor suppression, cell cycle checkpoints, apoptosis, migration, and organ size regulation.
LATS is an enzyme in the Hippo pathway that directly acts on YAP. It achieves two coordinated mechanisms, namely "cytoplasmic retention" and "primer-mediated protein degradation", by phosphorylating the Ser127 and Ser381 sites of YAP. As a result, it precisely and powerfully inhibits the oncogenic activity of YAP.
LATS is an enzyme in the Hippo pathway that directly acts on YAP. It achieves two coordinated mechanisms, namely "cytoplasmic retention" and "primer-mediated protein degradation", by phosphorylating the Ser127 and Ser381 sites of YAP. As a result, it precisely and powerfully inhibits the oncogenic activity of YAP.
All Product Categories
-
Large Tumor Suppressor (LATS) Related Products (11)
- 1
-
TRULI
0 ImagesSynonyms: Lats-IN-1TRULI (Lats-IN-1) is a potent and ATP-competitive inhibitor of Lats1 and Lats2 kinases. TRULI promotes Yap-dependent proliferation in postmitotic mammalian tissues. -
loading...loading...
-
-
TDI-011536
0 ImagesTDI-011536 is a potent Lats kinase inhibitor, interrupts Hippo-Yap signaling and initiates the proliferation of lesioned heartmuscle cells. TDI-011536 can be used in studies of organ conservation and regeneration. -
loading...loading...
-
-
NIBR-LTSi
0 ImagesCat. No.: HY-160769Purity: 99.97%NIBR-LTSi is an orally active and selective LATS kinase inhibitor. NIBR-LTSi can activate YAP signaling. NIBR-LTSi promotes stem cell proliferation, maintains stemness and blocks differentiation. NIBR-LTSi accelerates liver regeneration following extended hepatectomy in mice. -
loading...loading...
-
-
GA-017
0 ImagesGA-017 is a potent and selective LATS1 and LATS2 (large tumor suppressor kinase 1/2) inhibitor, with IC50 values of 4.10 and 3.92 nM, respectively. GA-017 is an activator of cell proliferation. GA-017 promotes YAP/TAZ activation and nuclear translocation. GA-017 promotes cell growth under 3D culture conditions. GA-017 enhances the ex vivo formation of mouse intestinal organoids. -
loading...loading...
-
-
VT02956
0 ImagesVT02956 is a LATS inhibitor (IC50: 0.76 nM for LATS1, 0.52 nM for LATS2). VT02956 targets the Hippo pathway. VT02956 inhibits ESR1 expression and growth of ER+ breast cancer cell lines and patient-derived tumor organoids. VT02956 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. -
loading...loading...
-
-
α-Ionone
0 Imagesα-Ionone (alpha-Ionone) is an activator of the olfactory receptor OR10A6. α-Ionone induces apoptosis by activating OR10A6 and increasing the phosphorylation of the LATS-YAP-TAZ signaling axis in the Hippo pathway. α-Ionone can inhibit tumor formation both in vivo and in vitro. -
loading...loading...
-
-
LATS-IN-2
0 ImagesLATS-IN-2 is an efficiently acting LATS (large tumor suppressor kinase) inhibitor. LATS-IN-2 shows potent inhibitory activity against LATS1 with an IC50 value of 1.3 nM. LATS-IN-2 suppresses the phosphorylation of YAP by inhibiting LATS kinase activity. LATS-IN-2 increases the thickness of the epidermis in mice. LATS-IN-2 can be used for the study of ocular diseases such as limbal stem cell deficiency and corneal endothelial dysfunction. -
loading...loading...
-
-
Cardiomyocyte proliferation promoting agent-1
0 ImagesSynonyms: (E/Z)-GA-002Cardiomyocyte proliferation promoting agent-1 ((E/Z)-GA-002), which is an E/Z mixture, is a cardiomyocyte proliferation promoter. GA-002 (single E configuration) is a kinase inhibitor for LATS1 and LATS2, with its IC50 values being 3.93 nM and 3.87 nM respectively. GA-002 can induce the expression of genes regulated by the Hippo pathway, inhibit the phosphorylation of YAP/TAZ, and induce the nuclear translocation of YAP. -
loading...loading...
-
-
DDO-4033
0 ImagesCat. No.: HY-175247Purity: 99.11%DDO-4033 is a SPOP inhibitor (IC50 = 16.9 μM, Kd = 15.1 μM). DDO-4033 impairs the malignant migration, invasion, and proliferation of clear cell renal cell carcinoma (ccRCC) cell lines. DDO-4033 disrupts SPOP recruitment to its substrate LATS1, inhibits its polyubiquitination and subsequent degradation, and upregulates LATS1 expression. DDO-4033 has promising antitumor activity and is promising for renal cell carcinoma research. -
loading...loading...
-
-
LATS1/2-IN-1
0 ImagesCat. No.: HY-175649CAS No.: 3024011-99-9LATS1/2-IN-1 is a potent and selective LATS1 and LATS2 inhibitor. LATS1/2-IN-1 exhibits potent inhibitory activity against LATS1 and LATS2 with IC50 values of 4.4 nM and 5.5 nM as determined via r33P functional assay. LATS1/2-IN-1 displays cellular IC50 values of 136 nM for LATS1 and 36.0 nM for LATS2 as determined via NanoBRET assay. LATS1/2-IN-1 reduces phosphorylation of YAP1 in mouse liver. LATS1/2-IN-1 demonstrates wound healing activity in HT-1080 scratch assay and in vivo SKH1 mouse punch biopsy model. LATS1/2-IN-1 can be used for the study of regenerative medicine indications such as wound healing. -
loading...loading...
-
-
VT02956 hydrochloride
0 ImagesCat. No.: HY-147165AVT02956 is a LATS inhibitor (IC50: 0.76 nM for LATS1, 0.52 nM for LATS2). VT02956 targets the Hippo pathway. VT02956 inhibits ESR1 expression and growth of ER+ breast cancer cell lines and patient-derived tumor organoids. VT02956 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. -
loading...loading...
-
- 1
